231 related articles for article (PubMed ID: 37925676)
1. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus.
Eryavuz Onmaz D; Tezcan D; Yilmaz S; Onmaz M; Unlu A
Amino Acids; 2023 Dec; 55(12):1937-1947. PubMed ID: 37925676
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
[TBL] [Abstract][Full Text] [Related]
3. Impaired kynurenine metabolism in patients with primary Sjögren's syndrome.
Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sak F; Humeyra Yerlikaya F; Yilmaz S; Abusoglu G; Kazim Korez M; Unlu A
Clin Biochem; 2023 Apr; 114():1-10. PubMed ID: 36681140
[TBL] [Abstract][Full Text] [Related]
4. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
5. Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus.
Anderson EW; Fishbein J; Hong J; Roeser J; Furie RA; Aranow C; Volpe BT; Diamond B; Mackay M
Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34686589
[TBL] [Abstract][Full Text] [Related]
6. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
9. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
10. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
[TBL] [Abstract][Full Text] [Related]
11. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
Almulla AF; Vasupanrajit A; Tunvirachaisakul C; Al-Hakeim HK; Solmi M; Verkerk R; Maes M
Mol Psychiatry; 2022 Sep; 27(9):3679-3691. PubMed ID: 35422466
[TBL] [Abstract][Full Text] [Related]
12. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
[TBL] [Abstract][Full Text] [Related]
13. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever.
Tezcan D; Onmaz DE; Sivrikaya A; Körez MK; Hakbilen S; Gülcemal S; Yılmaz S
Mod Rheumatol; 2023 Mar; 33(2):398-407. PubMed ID: 35139221
[TBL] [Abstract][Full Text] [Related]
15. Accelerated kynurenine pathway downregulates immune activation in patients with axial spondyloarthritis.
Yurt EF; Biçer C; Serdar MA; Akan S; Erten Ş
Cytokine; 2023 Sep; 169():156247. PubMed ID: 37295242
[TBL] [Abstract][Full Text] [Related]
16. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
[TBL] [Abstract][Full Text] [Related]
18. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
Song P; Ramprasath T; Wang H; Zou MH
Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
[TBL] [Abstract][Full Text] [Related]
19. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
[TBL] [Abstract][Full Text] [Related]
20. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
